Display Settings:


Send to:

Choose Destination
See comment in PubMed Commons below
Stem Cell Rev. 2007 Dec;3(4):280-8.

From stem cells to oligodendrocytes: prospects for brain therapy.

Author information

  • 1Department of Surgery (Neurosurgery), UMDNJ-Robert Wood Johnson Medical School, 675 Hoes Lane, S-225, Piscataway, NJ, 08854, USA.


Multiple sclerosis is an autoimmune disease that destroys myelin-forming oligodendrocytes of the CNS. While the damage can be partially controlled using anti-inflammatory cytokines and steroids, endogenous repair is insufficient to replace lost cells. Until now cell replenishment (transplant therapy) has been viewed as unlikely to succeed due to allograft rejection in this sensitized immune environment. However, advances in stem cell biology give new hope for deriving patient-specific, autologous oligodendrocytes which may tip the balance to favor repair. The challenge will be to engineer these cells to respond to cues that can target their migration into lesions for brain and spinal cord repair.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Icon for Springer
    Loading ...
    Write to the Help Desk